Publications
Export 26 results:
Filtres: Author is Marie-France Demers [Enlever les filtres]
, « A Chart Audit Study of Clozapine Utilization in Early Psychosis. », J Clin Psychopharmacol, vol. 41, nᵒ 3, p. 275-280, 2021.
, « Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series. », J Psychopharmacol, vol. 35, nᵒ 9, p. 1152-1157, 2021.
, « Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program. », CNS Drugs, vol. 35, nᵒ 4, p. 461-468, 2021.
, « Circulating IGFBP-2 levels reveal atherogenic metabolic risk in schizophrenic patients using atypical antipsychotics. », World J Biol Psychiatry, p. 1-8, 2020.
, « Problem Gambling Associated With Aripiprazole in First-Episode Psychosis Patients: A Series of 6 Case Reports. », J Clin Psychopharmacol, vol. 40, nᵒ 2, p. 191-194, 2020.
, « "Real world" clinical effectiveness of paliperidone palmitate 3-monthly injectable in early psychosis patients. », Psychopharmacology (Berl), 2020.
, « Case Reports of Aripiprazole and Problematic Gambling in Schizophrenia: A Critical Review of the Evidence. », J Clin Psychopharmacol, vol. 39, nᵒ 4, p. 393-397, 2019.
, « Continuing clozapine despite recurrent neutropenia: A 8 year follow-up case report with granulocyte-colony stimulating factor as-required use. », Asian J Psychiatr, 2018.
, « More intensive probing increases the detection of social anxiety disorders in schizophrenia. », Psychiatry Res, vol. 268, p. 358-360, 2018.
, « Social anxiety disorder in schizophrenia: a neglected, yet potentially important comorbidity. », J Psychiatry Neurosci, vol. 43, nᵒ 4, p. 287-288, 2018.
, « [Initiating an antipsychotic drug treatment for schizophrenia: the situation in Quebec, Canada, from 1998 to 2006]. », Sante Ment Que, vol. 42, nᵒ 1, p. 85-103, 2017.
, « One year mirror-image study using paliperidone palmitate for relapse prevention of schizophrenia in four university hospitals in Canada. », Schizophr Res, vol. 185, p. 96-100, 2017.
, « Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real-world observational study. », Acta Psychiatr Scand, vol. 134, nᵒ 5, p. 374-384, 2016.
, « Comorbidity between anxiety disorders and recent-onset psychotic disorders. », Schizophr Res, vol. 166, nᵒ 1-3, p. 353-4, 2015.
, « Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia. », Am J Drug Alcohol Abuse, vol. 34, nᵒ 1, p. 75-82, 2008.
, « Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. », J Psychopharmacol, vol. 22, nᵒ 3, p. 262-9, 2008.
, « Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial. », Curr Med Res Opin, vol. 22, nᵒ 7, p. 1277-85, 2006.
, « Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics. », J Clin Psychiatry, vol. 65, nᵒ 4, p. 557-64, 2004.
, « First person account: Susan's cello. », Schizophr Bull, vol. 28, nᵒ 1, p. 187-9, 2002.
, « Atypical antipsychotics and cardiovascular risk in schizophrenic patients. », J Clin Psychopharmacol, vol. 21, nᵒ 1, p. 110-1, 2001.
, « [Psychosis and addiction: the experience of the Polyclinique Sainte-Anne.]. », Sante Ment Que, vol. 26, nᵒ 2, p. 62-91, 2001.
, « Longitudinal comparative study of risperidone and conventional neuroleptics for treating patients with schizophrenia. The Quebec Schizophrenia Study Group. », J Clin Psychopharmacol, vol. 20, nᵒ 3, p. 295-304, 2000.
, « [Schizophrenia and psychoactive drug abuse: dual diagnostic problem]. », Can J Psychiatry, vol. 45, nᵒ 6, p. 572-3, 2000.
, « Visual and auditory hallucinations with the association of bupropion and valproate. », Can J Psychiatry, vol. 45, nᵒ 2, p. 198-9, 2000.
